Numeric Investors’s Syndax Pharmaceuticals SNDX Stock Holding History

Numeric Investors’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,057	Closed	-$152K	–	1145
2017 Q1	$152K	Buy	+11,057	New	+$115K	﹤0.01%	975

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Numeric Investors's SNDX Position: Q2 2017 in Review

Numeric Investors sold out of Syndax Pharmaceuticals (SNDX) in Q2 2017, closing a stake of 11,057 shares — an estimated $152K sold.

Numeric Investors first reported a position in SNDX in Q1 2017 and held it in 1 quarter. The position peaked at $152K in Q1 2017. 66 funds tracked by Wall St. Rank hold SNDX as of Q2 2017.

Numeric Investors reported no remaining Syndax Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Numeric Investors sold 11,057 Syndax Pharmaceuticals shares in Q2 2017, an estimated $152K.
Numeric Investors first reported a position in Syndax Pharmaceuticals in Q1 2017 and held it in 1 quarter.
Numeric Investors's Syndax Pharmaceuticals position peaked at $152K in Q1 2017.
66 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2017.

Based on Numeric Investors's 13F filing for Q2 2017, filed 14 Aug 2017.